Ubrogepant, approved for acute treatment of migraine, may also reduce nonheadache symptoms that occur in the hours preceding ...

If you're a migraine sufferer familiar with that early "aura" and other symptoms that pop up before the main pain hits, the ...

Tonix Pharmaceuticals (NASDAQ: TNXP) , a fully-integrated biopharmaceutical company, announced financial results for the first quarter of 2025 and re ...

FDA PDUFA goal date of August 15, 2025, for TNX-102 SL for the management of fibromyalgia; if approved, TNX-102 SL would become the first new drug for treating fibromyalgia in more than 15 years Annou ...

Fremanezumab is linked to a greater reduction in monthly migraine days and symptoms of depression in adults with both ...

Erenumab significantly improved quality of life and disability among patients with chronic and episodic migraine over a 2-year period.

The trial was only run on those who can reliably detect migraine warning signs early, but among them, timing made a big ...

Experiencing a migraine involves severe headaches, but they don’t show up alone. They are often accompanied by what the Mayo ...